MetLife Investment Management’s Safeguard Scientifics, Inc. SFE Stock Holding History

MetLife Investment Management’s Portfolio SFE Stock Details SFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,000	Closed	-$113K	–	2343
2019 Q3	$113K	Hold	10,000	–	–	﹤0.01%	2268
2019 Q2	$121K	Buy	+10,000	New	+$117K	﹤0.01%	2302
2018 Q3	–	Sell	-10,084	Closed	-$129K	–	2636
2018 Q2	$129K	Hold	10,084	–	–	﹤0.01%	2132
2018 Q1	$124K	Hold	10,084	–	–	﹤0.01%	2118
2017 Q4	$113K	Buy	+10,084	New	+$129K	﹤0.01%	2183

Other funds holding SFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCM

Horton Capital Management Philadelphia, Pennsylvania $44.9M AUM 24.87% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.95% 1-Year Est. Return

ZIG

Zuckerman Investment Group Chicago, Illinois $1.07B AUM 29.43% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

MetLife Investment Management's SFE Position: Q4 2019 in Review

MetLife Investment Management sold out of Safeguard Scientifics, Inc. (SFE) in Q4 2019, closing a stake of 10,000 shares — an estimated $113K sold.

MetLife Investment Management first reported a position in SFE in Q4 2017 and held it in 5 quarters. The position peaked at $129K in Q2 2018. 91 funds tracked by Wall St. Rank hold SFE as of Q4 2019.

MetLife Investment Management reported no remaining Safeguard Scientifics, Inc. position as of Q4 2019 after selling out during the quarter.
MetLife Investment Management sold 10,000 Safeguard Scientifics, Inc. shares in Q4 2019, an estimated $113K.
MetLife Investment Management first reported a position in Safeguard Scientifics, Inc. in Q4 2017 and held it in 5 quarters.
MetLife Investment Management's Safeguard Scientifics, Inc. position peaked at $129K in Q2 2018.
91 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q4 2019.

Based on MetLife Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.